JPRN-UMIN000012262招募中未知
Comparison study of the effects between DPP-4 inhibitor and sulfonylurea on glucagon secretion in type 2 diabetic patients treated with biguanide - DPP-4 inhibitor and sulfonylurea on glucagon secretion in type 2 diabetic patients treated with biguanide
Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine0 个研究点目标入组 40 人开始时间: 2013年11月20日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)iabets mellitus due to glucagon-producing tumor 2) patients:the medicine is changed within the last three months 3) Type 1 diabtes,HbA1c: higher than 10.5%,patients who require hospitalization for high blood glucose or diabetic ketoasidosis 4) patients treated with Dpp-4 inhibitor, sulfonylurea or insulin injection 5)patients with nephrotic syndrome 6) hypersensitivity to drugs on this study 7) renal dysfunction (1.3 and 1.2 mg/dL or more for male and female, respectively) 8)hepatitis (AST,ALT: three folds higher than baseline), 9) pregnancy, possibly pregnant woman 10) patients who are inadequate to enter this study due to the other reasons by physician's judgments
研究者
相似试验
已完成
不适用
Comparison of efficacy between DPP-4 inhibitor up-titration vs addition of acarbose in T2DMtype 2 diabetes mellitusJPRN-UMIN000005471Saitama Medical University40
招募中
不适用
Comparison of effects of a DPP-4 inhibitor and an alpha-glucosidase inhibitor on visceral fat and oxidative stress in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000011864Tokyo Women's Medical University100
进行中（未招募）
不适用
valuation of the effect of a new drug for diabetes on atherosclerosis in patients with primary failure metformiType 2 diabetesMedDRA version: 14.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000152-34-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA64
已完成
不适用
Study of the combination use effect of DPP-4 inhibitor and alpha-glucosidase inhibitortype 2 diabetesJPRN-UMIN000008692Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine60
已完成
不适用
Effects of concomitant administration of DPP-4 and SGLT2 inhibitors in Japanese patients with type 2 diabetesType 2 diabetesJPRN-UMIN000026442agoya University220